LRRC15 and breast neoplasm: LRRC15 showed a strong expression in breast tumor tissues (100%), with +2 staining in 1% of the tissues and +3 staining in 99%, while EFNA3 exhibited strong positivity in 90% of the tissues, ranging from 0 (10%), +1 (17%), +2 (22%), to +3 (51%).